{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33974565",
  "DateCompleted": {
    "Year": "2021",
    "Month": "06",
    "Day": "28"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "07",
    "Day": "16"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "e151186",
      "10.1172/JCI151186",
      "151186"
    ],
    "Journal": {
      "ISSN": "1558-8238",
      "JournalIssue": {
        "Volume": "131",
        "Issue": "12",
        "PubDate": {
          "Year": "2021",
          "Month": "Jun",
          "Day": "15"
        }
      },
      "Title": "The Journal of clinical investigation",
      "ISOAbbreviation": "J Clin Invest"
    },
    "ArticleTitle": "What should define a SARS-CoV-2 \"breakthrough\" infection?",
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Tulane Department of Pediatrics."
          }
        ],
        "LastName": "Schieffelin",
        "ForeName": "John S",
        "Initials": "JS"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Tulane Department of Microbiology and Immunology, and."
          }
        ],
        "LastName": "Norton",
        "ForeName": "Elizabeth B",
        "Initials": "EB"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Center for Translational Research in Infection and Inflammation, Tulane School of Medicine, New Orleans, Louisiana, USA."
          }
        ],
        "LastName": "Kolls",
        "ForeName": "Jay K",
        "Initials": "JK"
      }
    ],
    "GrantList": [
      {
        "GrantID": "U54 CA260581",
        "Acronym": "CA",
        "Agency": "NCI NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "U54 GM104940",
        "Acronym": "GM",
        "Agency": "NIGMS NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "J Clin Invest",
    "NlmUniqueID": "7802877",
    "ISSNLinking": "0021-9738"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "COVID-19 Vaccines"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "epidemiology",
        "immunology",
        "pathology",
        "prevention & control"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "COVID-19 Vaccines"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Immunity, Mucosal"
    },
    {
      "QualifierName": [
        "immunology"
      ],
      "DescriptorName": "SARS-CoV-2"
    }
  ]
}